Clinical Trials Directory

Trials / Completed

CompletedNCT03319108

Comorbidity and Pulmonary Rehabilitation in COPD

The Effect of Severity of Co-morbidity on Outcomes of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
173 (actual)
Sponsor
Izmir Katip Celebi University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes.

Detailed description

Chronic Obstructive Pulmonary Disease (COPD) is associated not only with respiratory system effects but also with systemic outcomes leading to numerous chronic comorbidities, and it is well known that patients benefit from pulmonary rehabilitation programs. However, the effect of presence of comorbidity on the outcome of pulmonary rehabilitation in patients with COPD is not clear. Therefore, our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes We included a total of 173 patients referred to the Izmir Suat Seren Chest Diseases and Surgery Training and Research Hospital Pulmonary Rehabilitation Unit. Comorbidities were recorded based on self reports. Charlson Comorbid Indexes (CCI) were calculated. Patients who defined at least one comorbidity were divided into two groups according to CCI; 1-3 as Group 1 and 4 and above as Group 2. Six minute walk test, mMRC dyspnea scale, SGRQ Respiratory Disease Questionnaire, respiratory function tests and arterial blood gases performed for assessment of patients before and after 16 sessions of pulmonary rehabilitation program.

Conditions

Interventions

TypeNameDescription
OTHERExercisePulmonary Rehabilitation Program for 8 weeks

Timeline

Start date
2013-01-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2017-10-24
Last updated
2017-10-24

Source: ClinicalTrials.gov record NCT03319108. Inclusion in this directory is not an endorsement.